| Literature DB >> 28566182 |
Sun-Young Kim1, Jin-Hong Shin2, Jin-Sung Park3, Sa-Yoon Kang4, Tai-Seung Nam5, Jong Kuk Kim6, Ki-Jong Park7, So-Young Huh8, Ji Seon Oh9, Boram Kang2, Dae-Seong Kim10.
Abstract
Azathioprine (AZA)-induced leukopenia is a relatively common complication in Korean patients. In addition to variation in TPMT (thiopurine S-methyltransferase), the NUDT15 p.R139C variant was recently identified to have a strong association with AZA-induced leukopenia. We investigated these associations in Korean patients undergoing AZA treatment with various neurological diseases. Among 84 enrolled patients, 20 (23.8%; 7 early, 13 late) exhibited leukopenia. The NUDT15 p.R139C variant was associated with leukopenia (OR: 11.844, 95% CI 3.984-36.024, p=1.327 × 10-5). The allelic frequency of NUDT15 p.R139C was as high as 10.7% and the frequency of the C/C, C/T, and T/T genotypes was 84.5, 10.7, and 5.9%, respectively. All T/T homozygous patients (5/5) developed early severe-grade leukopenia (white blood cells <1000mm-3) and severe alopecia. NUDT15 p.R139C was strongly associated with early leukopenia and severe alopecia (OR for early leukopenia: 107.624, 95% CI 18.857-614.250, p=1.403 × 10-7, OR for severe alopecia: 77.152, 95% CI 17.378-342.526, p=1.101 × 10-8). The sensitivity and specificity for predicting AZA-induced early leukopenia were 85.7% and 92.2%, respectively. Therefore, the NUDT15 p.R139C variant is common and strongly associated with AZA-induced early leukopenia and severe alopecia in Korean patients with various neurological diseases.Entities:
Keywords: Azathioprine; Korea; Leukopenia; NUDT15; TPMT
Mesh:
Substances:
Year: 2017 PMID: 28566182 DOI: 10.1016/j.jns.2017.04.041
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181